- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Wine-based antioxidantmay shield against radiation
What could be better? A little wine, a littlecheese-with a side of radiation protection.University of Pittsburgh researchers arestudying the radiation protective propertiesof resveratrol, a natural antioxidant commonlyfound in red wine and many plants.
What could be better? A little wine, a little cheese-with a side of radiation protection. University of Pittsburgh researchers are studying the radiation protective properties of resveratrol, a natural antioxidant commonly found in red wine and many plants.
Dr. Joel Greenberger and colleagues at Pitt's Center for Medical Countermeasures Against Radiation found that resveratrol,when altered with acetyl, shielded mouse cells from the effects of radiation. Greenberger's group had already made news in 2004 when it discovered the agent JP4-039, which can be delivered directly to mitochondria to resist radiation-induced cell death.
Greenberger's team released its latest findings on acetylated resveratrol at the 2008 American Society for Therapeutic Radiology and Oncology meeting in Boston.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
